A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.
Investigational Drug Gaining Traction Online
Retatrutide, which remains in research studies, is being advertised by social media influencers for its supposed weight-reducing effects. Followers are urged to message these accounts privately for supplier links, while also obtaining promotional offers.
Thriving Commerce on Messaging Platforms
Additionally, a robust trade exists on Telegram, where groups with numerous of members share “before and after” images, injection guides and claims of rapid British shipping. Sellers promote the drug there before directing customers to other platforms for transactions.
Learning About Retatrutide
Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.
Medical Experts Express Worries
Nevertheless, physicians and chemists have warned that the distribution of what is still an unapproved medication in the UK is a cause for concern and could result in users injecting products of unknown origin.
Some experts stated the popularity for retatrutide could be linked to the increasing price of approved slimming treatments such as Mounjaro.
Legal Position and Enforcement
Selling retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved medication that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Several influencers try to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still breach pharmaceutical, advertising, and customer regulations, risking fines, legal action or imprisonment.
Service Response and Content Elimination
Based on TikTok, the service has removed violative material and prohibited related hashtags and query recommendations. The company stated it was dedicated to keeping the service safe and allocating resources in enhancing enforcement strategies.
Digital Marketplace Activities
Investigations also discovered groups with up to nine thousand members selling the experimental drug using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly displays groups with thousands of members, filled with photos of weight loss, glowing reviews and detailed guides for preparing or injecting at home.
Within minutes of joining one community, a vendor shared contact information, where most transactions take place. The seller provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one inquired about weight, health issues or previous experience.
Item Information and Costs
Within these groups, messages show black plastic parcels with postal service labels, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at home with sterile water, or ready-to-use pens typically sold at 160 pounds for 20 milligrams. When asked how much time a pen should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.
Platform Oversight and Safety Measures
A spokesperson for the messaging service stated it regularly monitored dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are injecting substances they cannot confirm. Although the science behind this drug is valid, these digital versions may not include what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the surge in interest to recent price rises for approved slimming drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But fake injections are extremely dangerous. You cannot know what’s inside or whether the environment they were produced in was sterile,” she explained.
Her team has already encountered patients harmed by personal administration from unverified sources. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These substances could be impure or incorrectly dosed.”
Producer Statement
A representative from Eli Lilly stated the substance was in phase 3 research studies and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a company investigational product not yet approved … may expose users to potentially serious health risks”.
